Docoh
Loading...

ENZ Enzo Biochem

Enzo Biochem, Inc. engages in the development, manufacture and sale of technology solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians globally. It operates through the following segments: Enzo Clinical Laboratory Services, Enzo Life Sciences Products, and Enzo Therapeutics. The Enzo Clinical Laboratory Services segment includes clinical reference laboratory providing a wide range of clinical services to physicians, medical centers, other clinical labs and pharmaceutical companies. The Enzo Life Sciences Products segment manufactures, develops and markets products and tools for clinical research, drug development and bioscience research customers worldwide. The Enzo Therapeutics segment develops multiple novel approaches in the areas of gastrointestinal, infectious, ophthalmic and metabolic diseases, many of which are derived from the pioneering work of Enzo Life Sciences. The company was founded by Elazar Rabbani, Barry W. Weiner and Shahram K. Rabbani in 1976 and is headquartered in New York, NY.

Company profile

Ticker
ENZ
Exchange
Website
CEO
Elazar Rabbani
Employees
Incorporated
Location
Fiscal year end
SEC CIK
IRS number
132866202

ENZ stock data

(
)

Calendar

16 Mar 21
22 Apr 21
31 Jul 21
Quarter (USD)
Jan 21 Oct 20 Jul 20 Apr 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Jul 20 Jul 19 Jul 18 Jul 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 45.29M 45.29M 45.29M 45.29M 45.29M 45.29M
Cash burn (monthly) 459.33K 580.5K (positive/no burn) 946.33K 273.33K 934.67K
Cash used (since last report) 1.26M 1.59M n/a 2.6M 749.97K 2.56M
Cash remaining 44.03M 43.69M n/a 42.69M 44.54M 42.72M
Runway (months of cash) 95.8 75.3 n/a 45.1 162.9 45.7

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
16 Mar 21 Harbert Management Common Stock Sell Dispose S Yes No 4.539 100,000 453.9K 5,175,913
16 Mar 21 Harbert Management Common Stock Sell Dispose S Yes No 4.7 200,000 940K 5,275,913
15 Mar 21 Harbert Management Common Stock Sell Dispose S Yes No 5 44,768 223.84K 5,475,913
15 Mar 21 Harbert Management Common Stock, $0.01 par value ("Common Stock") Sell Dispose S Yes No 4.75 100,000 475K 5,520,681
11 Jan 21 Ian B. Walters Stock Option (to acquire Common Stock) Common Stock Grant Aquire A No No 2.63 77,101 202.78K 77,101
11 Jan 21 David Bench Stock Option (to acquire Common Stock) Common Stock Grant Aquire A No No 2.63 55,400 145.7K 110,800
11 Jan 21 Elazar Rabbani Common Stock, par value $0.01 per share Grant Aquire A No No 0 190,114 0 2,262,208
11 Jan 21 Perlysky Dov Stock Option (to acquire Common Stock) Common Stock Grant Aquire A No No 2.63 77,101 202.78K 335,780

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

72.4% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 83 83
Opened positions 7 9 -22.2%
Closed positions 7 10 -30.0%
Increased positions 24 23 +4.3%
Reduced positions 24 27 -11.1%
13F shares
Current Prev Q Change
Total value 108.89M 81.84M +33.1%
Total shares 34.9M 28.92M +20.7%
Total puts 163K 34.2K +376.6%
Total calls 53.5K 37.8K +41.5%
Total put/call ratio 3.0 0.9 +236.7%
Largest owners
Shares Value Change
Harbert Fund Advisors 5.62M $14.16M 0.0%
Harbert Discovery Fund 5.62M $14.67M NEW
BLK Blackrock 3.76M $9.46M +4.1%
Renaissance Technologies 3.56M $8.96M -0.9%
Roumell Asset Management 2.77M $6.98M +17.6%
Evermore Global Advisors 2.61M $6.57M -11.7%
Vanguard 2.4M $6.04M +0.7%
Dimensional Fund Advisors 1.7M $4.29M -11.4%
Ariel Investments 871.11K $2.2M +4.8%
STT State Street 847.55K $2.14M +4.7%
Largest transactions
Shares Bought/sold Change
Harbert Discovery Fund 5.62M +5.62M NEW
Roumell Asset Management 2.77M +415K +17.6%
Evermore Global Advisors 2.61M -344.6K -11.7%
Dimensional Fund Advisors 1.7M -219.58K -11.4%
VIEX Capital Advisors 155.48K +155.48K NEW
BLK Blackrock 3.76M +146.25K +4.1%
Russell Investments 0 -125.29K EXIT
Group One Trading 140.13K +119.9K +592.8%
JPM JPMorgan Chase & Co. 132.22K +111.23K +530.0%
Simplex Trading 122.04K +103.77K +567.9%
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: ACLA, appointing, assigned, bank, calendar, fewer, impose, intermediary, larger, lending, median, methodology, nineteen, opposition, paper, qualify, reform, senior, stringent
Removed: awarded, comparative, geography, substantially, timing, updated, variance, vested